Just started taking Oriahnn?

If you’ve started taking Oriahnn in the last 30 days for heavy menstrual bleeding associated with uterine fibroids, we want to hear from you. You may be eligible for up to $100 for completing all surveys and tasks in the study.

Fill out the pre-screening form below

What will I have to do?

see if you qualify

Fill out the pre-screener questionnaire above to see if you meet the basic qualifications.

get started ON the CONNECTION PORTAL

If you qualify, you will gain access to the Connection portal where you will find out more information about the study and sign the informed consent forms. Here you will also fill out your baseline survey and provide proof of prescription.

complete all surveys

Once the baseline period is complete, you will have follow-up surveys to complete on the Connection portal at 1 month, 3 months, and 6 months. 

Frequently Asked Questions

What is the purpose of this study?

The purpose of this study is to understand the impact of Oriahnn in a real-world setting. This study aims to find out more about how it impacts menstrual bleeding, treatment choices in the future, and overall quality of life. 

What do I need to do to participate?

Potential participants will need to complete the pre-screening form above. Once in the study you will need to provide proof of a prescription for Oriahnn and to answer the online surveys at baseline and months 1, 3, and 6. Reliable internet is required. 

Is there compensation for my participation?

Yes! If all study-related activities are completed, participants may receive a total of $100. How it works is that you are eligible to receive $25 after completing the baseline tasks and then you are eligible to receive an additional $25 per completed touch point at the end of month 1, month 3, and month 6. 

Is participation voluntary?

Participation is completely voluntary and can be ended at any time.

Does it cost anything to participate?

No, it doesn’t cost anything to participate in this study.

Trusted Researchers

AbbVie is a research-driven pharmaceutical company whose researchers and scientists are continuously working on new approaches to health issues with special focus on diseases that are difficult to cure. You can learn more about AbbVie here.


Participation from home

Those participating can do all study related activities from the comfort of their own home via the online Connection portal. No in-person visits or phone calls are required. 

study Details

The purpose of this study is to understand the experiences of those taking Oriahnn for heavy menstrual bleeding. The study will gather information about you and your background, your medical history, and ask questions related to your experiences taking Oriahnn. To learn more about this study, you can go to this link: (study link here).

Please note: 1nHealth may store your data in a confidential and secure database. That personal information will never be shared or sold with any other persons or organizations not associated with 1nHealth. 1nHealth may/will use personal information to contact you directly by phone and/or email for matters related to potential participation in clinical trials for which the potential subject may qualify. See our Privacy Policy for more details.